Earnings History Data for Interpace Biosciences (IDXG) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Interpace Biosciences
Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-03-2023 | AH | IDXG | Interpace Biosciences | 4.00 | -0.33 | -0.07 | 0.00 | Interpace Biosciences GAAP EPS of -$0.33, revenue of $8.33M [3/27/2023 5:18 PM] |
1.01 | -0.05 (-5.14%) |
0.0 | 0.0 (0.00%) |
0.51 - 5.20 | 3,300 | 0 | 0 | ||
| 31-03-2021 | AH | After the close (Mar 31) |
IDXG | Interpace Biosciences, Inc. | 20.00 | -2.00 | -1.32 | 0.00 | Interpace Biosciences EPS misses by $0.69, beats on revenue [3/31/2021 5:27 PM] |
6.30 | 1.56 (32.77%) |
0.0 | 0.0 (0.00%) |
2.57 - 8.32 | 466,991 | 0 | 0 | |
| 20-01-2021 | PM | IDXG | Interpace Diagnostics Group, Inc. | 17.00 | -1.53 | -1.36 | 0.00 | Interpace Biosciences EPS misses by $0.33, beats on revenue [1/20/2021 8:45 AM] |
4.34 | -0.24 (-5.24%) |
4.26 | -0.32 (-6.99%) |
2.57 - 11.00 | 268,263 | 169,352 | 106,380 | ||
| 19-10-2020 | PM | IDXG | Interpace Diagnostics Group, Inc. | 18.00 | -1.35 | -1.64 | 0.00 | Interpace Biosciences EPS misses by $0.32, misses on revenue [10/20/2020 8:18 AM] |
3.99 | -0.02 (-0.50%) |
3.46 | -0.53 (-13.28%) |
2.57 - 11.00 | 283,347 | 5,229,240 | 3,113 | ||
|
|
||||||||||||||||||